Thymoglobulin reverses acute renal allograft rejection better than ATGAM--a double-blinded randomized clinical trial

Transplant Proc. 1997 Nov;29(7A):21S-23S.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase III
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Animals
  • Antilymphocyte Serum / therapeutic use*
  • Double-Blind Method
  • Female
  • Graft Rejection / therapy*
  • Humans
  • Kidney Transplantation / immunology*
  • Male
  • Middle Aged
  • Rabbits

Substances

  • Antilymphocyte Serum